| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 11/26/2009 | US20090292113 Recombinant soluble Fc receptors |
| 11/26/2009 | US20090292024 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 11/26/2009 | US20090292000 Pyrrolidine derivatives as prostaglandin modulators |
| 11/26/2009 | US20090291982 New Substituted Oxindole Derivative 352 |
| 11/26/2009 | US20090291917 Boron-Containing Small Molecules as Anti-Inflammatory Agents |
| 11/26/2009 | US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease |
| 11/26/2009 | DE10317922B4 Verwendung eines Kombinationspräparates aus oralem Kontrazeptivum und Calcium/Vitamin D The use of a combination product of oral contraceptive and calcium / vitamin D |
| 11/26/2009 | CA2761971A1 Rice bran extracts for inflammation and methods of use thereof |
| 11/26/2009 | CA2725047A1 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
| 11/26/2009 | CA2724592A1 Agent for maintenance of induced remission |
| 11/26/2009 | CA2724357A1 Novel thiophenediamine derivative having urea structure |
| 11/25/2009 | EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor |
| 11/25/2009 | EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses |
| 11/25/2009 | EP2123654A1 Pyrazolopyrimidine compound |
| 11/25/2009 | EP2123652A1 Heterocyclic compound |
| 11/25/2009 | EP2121755A1 Antibodies specific for dkk-1 |
| 11/25/2009 | EP2120912A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 11/25/2009 | EP2120898A1 Calcilytic compounds |
| 11/25/2009 | EP1653994B1 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 11/25/2009 | EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 11/25/2009 | EP1242385B1 Cytokine, especially tnf-alpha, inhibitors |
| 11/25/2009 | EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation |
| 11/25/2009 | CN101589047A Cathepsin proteases inhibitors |
| 11/25/2009 | CN101585866A Polypeptide for regulating activity of FGFR3 and screening method and application thereof |
| 11/25/2009 | CN101585858A Application of glycosylated puerarin derivate and its combination for preventing and treating cardiovascular and cerebrovascular disease |
| 11/25/2009 | CN101585823A New immunosuppressive agent extracted from Honghuoma and extraction method and use thereof |
| 11/25/2009 | CN101584855A Pharmaceutical preparation and preparation method thereof |
| 11/25/2009 | CN101584846A Chinese medicament for treating cervical spondylosis |
| 11/25/2009 | CN101584809A Medicine for treating cold grasserie and method of preparing the medicine |
| 11/25/2009 | CN101584787A Medicine for external application for treating bone fracture and injury of tendons |
| 11/25/2009 | CN101584756A Medicament for treating gouty arthritis |
| 11/25/2009 | CN101584755A External liquid medicine for treating rheumatism bone pains and traumatic injuries and preparation method thereof |
| 11/25/2009 | CN101584684A Enteric preparation containing stable salts of S-adenosyl-L-methionine and preparation method thereof |
| 11/25/2009 | CN100562339C Remedies for infact chronic arthritis-relating diseases |
| 11/24/2009 | US7622487 Piperidine derivative, process for producing the same, and use |
| 11/24/2009 | US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 11/24/2009 | CA2475712C Nicotinamide derivatives useful as pde4 inhibitors |
| 11/24/2009 | CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 11/24/2009 | CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/24/2009 | CA2385882C Tyrosine derivatives |
| 11/24/2009 | CA2350638C Biologically active implants coated with a biodegradable polymer |
| 11/24/2009 | CA2201105C Inhibitor of stem cell proliferation and uses thereof |
| 11/19/2009 | WO2009140448A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 11/19/2009 | WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 11/19/2009 | WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors |
| 11/19/2009 | WO2009097228A4 Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| 11/19/2009 | WO2008081233A3 Cissus quadrangularis plant extracts for treating osteoporosis and the extraction process thereof |
| 11/19/2009 | US20090286986 Isoindole-imide compounds, compositions, and uses thereof |
| 11/19/2009 | US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few |
| 11/19/2009 | US20090286793 Pde4b inhibitors and uses therefor |
| 11/19/2009 | US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent |
| 11/19/2009 | US20090286782 Compounds and methods for kinase modulation, and indications therefor |
| 11/19/2009 | US20090286772 2-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]Imidazoles |
| 11/19/2009 | US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 11/19/2009 | US20090285822 Prevention and treatment of amyloidogenic disease |
| 11/19/2009 | US20090285816 Albumin Fusion Proteins |
| 11/19/2009 | US20090285809 Prevention and treatment of amyloidogenic diseases |
| 11/19/2009 | US20090285753 Novel haptotactic peptides |
| 11/19/2009 | DE112007003136T5 Ein Extrakt An extract |
| 11/19/2009 | CA2724629A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 11/19/2009 | CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 11/18/2009 | EP2119785A1 Novel peptides |
| 11/18/2009 | EP2119767A1 Method for preparation of cartilage cell |
| 11/18/2009 | EP2119718A1 Macrocyclic compound |
| 11/18/2009 | EP2119445A1 Prophylactic agent for autoimmune disease |
| 11/18/2009 | EP2119438A1 Bone metabolism ameliorating agent |
| 11/18/2009 | EP2117547A1 1,2,3,4-tetrahydroisoquinoline derivatives having effects of preventing and treating degenerative and inflammatory diseases |
| 11/18/2009 | EP2117523A1 Inhibitors of akt activity |
| 11/18/2009 | EP1928842B1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 11/18/2009 | EP1490064B1 Substituted pyridinones as modulators of p38 map kinase |
| 11/18/2009 | EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 11/18/2009 | EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses |
| 11/18/2009 | EP1207873B1 Methods of inhibiting osteoclast activity |
| 11/18/2009 | CN101583369A Topical formulation and uses thereof |
| 11/18/2009 | CN101583367A Materials and methods for treating and managing angiogenesis-mediated diseases |
| 11/18/2009 | CN101580833A SiRNA for inhibiting rat Atpase a3 gene expression, recombinant slow virus and application in medicament for treating bone absorption abnormal diseases |
| 11/18/2009 | CN101580496A 5-substituted phenyl-3-isoxazole carboxylic acid and ester compounds, compositions and preparation method thereof |
| 11/18/2009 | CN101580495A 5-substituted phenyl-3-isoxazole carboxylic acid and ester compounds, compositions and preparation method thereof |
| 11/18/2009 | CN101579520A Aplidine for the treatment of multiple myeloma |
| 11/18/2009 | CN101579512A Traditional Chinese medicine for treating cervical vertebra pain and prolapsed intervertebral disc pain |
| 11/18/2009 | CN101579504A Traditional Chinese medicine for treating chronic cervical spondylosis |
| 11/18/2009 | CN101579487A Capsule for treating bones and muscles |
| 11/18/2009 | CN101579459A Medicine for treating hyperosteogeny and diskal hernia and preparation method |
| 11/18/2009 | CN101579434A Traditional Chinese medicine preparation for curing femoral head necrosis and vasculitis |
| 11/18/2009 | CN101579419A Medicinal liquor for treating hyperosteogeny |
| 11/18/2009 | CN101579418A Transdermal patch for hyperosteogeny and preparation process thereof |
| 11/18/2009 | CN101579417A Chinese medicament for treating hyperosteogeny |
| 11/18/2009 | CN101579416A Orthopedics plaster and preparation method thereof |
| 11/18/2009 | CN101579390A Medicinal dripping pill for treating osteoporosis |
| 11/18/2009 | CN101579369A Medicinal composition for treating rickets and preparation method thereof |
| 11/18/2009 | CN101579368A Medicinal composition for treating rickets |
| 11/18/2009 | CN101579367A Medicinal dripping pill for treating rickets |
| 11/18/2009 | CN101579350A Phosphatide composite, preparation method and application thereof |
| 11/18/2009 | CN101579335A New formulation of medicament, preparation method and application method |
| 11/18/2009 | CN101579333A Medicament for treating soft tissue injury and arthritis and gel preparation method |
| 11/18/2009 | CN101579318A Bulleyaconitine A lipidosome freeze-dried powder injection and preparation method thereof |
| 11/18/2009 | CN100560124C Plaster for treating hyperosteogeny and pain, and its preparation method |
| 11/18/2009 | CN100560110C Chinese-medicinal compound preparation for treating injury |
| 11/18/2009 | CN100560109C External applied medicine for treating cervical vertebra disease, femoral head necrosis and diabetic foot |
| 11/18/2009 | CN100560108C Medicine composition for treating hyperosteogeny, and its preparing method |